Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 949.4 M1.08 B1.18 B1.16 B 4.37 B Research & development ———— — Operating income 273.6 M245.7 M471.3 M188.6 M 1.18 B Non-Operating Income, Total 4.4 M-2.9 M-7.5 M4.5 M -1.5 M Interest expense, net of interest capitalized 11.5 M15.9 M13.3 M13.5 M 54.2 M Non-Operating Income, excl. Interest Expenses -8.2 M-17.2 M-14.7 M-14.6 M -54.7 M Unusual income/expense 1.1 M-1.6 M-6.1 M5.6 M -1 M Pretax income 278 M242.8 M463.8 M193.1 M 1.18 B Equity in earnings ———— — Taxes 57.6 M35.3 M102.2 M41.5 M 236.6 M Non-controlling/minority interest ———— — After tax other income/expense 1.8 M-9.6 M2.4 M0 -5.4 M Net income before discontinued operations 220.4 M207.5 M361.6 M151.6 M 941.1 M Discontinued operations ———— — Net income 220.4 M207.5 M361.6 M151.6 M 941.1 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 220.4 M207.5 M361.6 M151.6 M 941.1 M Basic earnings per share (Basic EPS) 3.623.395.912.5 15.42 Diluted earnings per share (Diluted EPS) 3.523.325.822.45 15.11 Average basic shares outstanding 61 M61.1 M61.1 M61 M — Diluted shares outstanding 62.5 M62.4 M62.2 M62.3 M — EBITDA 329.1 M302.7 M531 M249.4 M 1.41 B EBIT 273.6 M245.7 M471.3 M188.6 M 1.18 B Cost of revenue 476.8 M644.3 M724.3 M599.9 M 2.45 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 55.5 M57 M59.7 M60.8 M 233 M